NextPlat (NXPL) Net Cash Flow (2010 - 2026)
NextPlat's (NXPL) quarterly Net Cash Flow came in at $936000.0 in Q2 2026, up 189.31% year-over-year from $323525.1 in Q2 2025, and up 134.36% quarter-over-quarter from -$2.7 million in Q1 2026.
Powered by 
Analysis
NextPlat (NXPL) Net Cash Flow (2010 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Net Cash Flow for 15 consecutive years, with $936000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Net Cash Flow rose 189.31% year-over-year to $936000.0 in Q2 2026; TTM through Jun 2026 was -$4.7 million, a 42.57% increase from a year earlier, with the FY2025 full-year figure at -$6.2 million, up 2.41% from the prior year.
- Net Cash Flow was $936000.0 for Q2 2026 at NextPlat, up from -$2.7 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $6.4 million in Q4 2022 and troughed at -$7.9 million in Q3 2022.
- A 5-year average of -$287166.7 and a median of -$737000.0 in 2024 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow jumped 5076.79% in 2022 and sank 5225.0% in 2024, its largest moves.
- Over 5 years, Net Cash Flow stood at $6.4 million in 2022, then tumbled by 100.13% to -$8000.0 in 2023, then slumped by 5225.0% to -$426000.0 in 2024, then jumped by 51.64% to -$206000.0 in 2025, then soared by 554.37% to $936000.0 in 2026.
- The last three Net Cash Flow figures came in at $936000.0 (Q2 2026), -$2.7 million (Q1 2026), and -$206000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | -81.00 Mn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | -912.40 Mn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | -44.45 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | -64.63 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 528.00 Mn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 48.97 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 78.82 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 52.66 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 936,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 936,000.00 |
| Mar 31, 2026 | -2.72 Mn |
| Dec 31, 2025 | -206,000.00 |
| Sep 30, 2025 | -2.72 Mn |
| Jun 30, 2025 | -1.05 Mn |
| Mar 31, 2025 | -2.22 Mn |
| Dec 31, 2024 | -426,000.00 |
| Sep 30, 2024 | -4.53 Mn |
| Jun 30, 2024 | 1.36 Mn |
| Mar 31, 2024 | -2.75 Mn |
| Dec 31, 2023 | -8,000.00 |
| Sep 30, 2023 | 5.72 Mn |
| Jun 30, 2023 | 3.90 Mn |
| Mar 31, 2023 | -2.15 Mn |
| Dec 31, 2022 | 6.36 Mn |
| Sep 30, 2022 | -7.92 Mn |
| Jun 30, 2022 | -1.42 Mn |
| Mar 31, 2022 | 4.67 Mn |
| Dec 31, 2021 | 122,873.00 |
| Sep 30, 2021 | 2.67 Mn |